Gastroparesis:  Clinical Evaluation of Drugs for Treatment
cder 2015-165 Gastroparesis
2015-10-02 2015-10-02 2019-10-22
FDA-2015-D-2479-0008 FDA-2015-D-2479-0009 FDA-2015-D-2479-0015
04:00:00 04:00:00 04:00:00
https://api.regulations.gov/v4/comments/FDA-2015-D-2479-0008 https://api.regulations.gov/v4/comments/FDA-2015-D-2479-0009 https://api.regulations.gov/v4/comments/FDA-2015-D-2479-0015
Anonymous Anonymous Vanda pharmaceuticals
Anonymous Anonymous Carlin
RE:  Docket No. FDA-2015-D-2479Federal Register / Vol. 80, No. 141 / Thursday, July 23, 2015Reference is made to the proposed Draft Guidance for Industry on Gastroparesis, published in the Federal Register notice referenced above. Ironwood Pharmaceuticals, Inc. is pleased and appreciative about the publication of this guidance document for development of drugs for gastroparesis and the opportunity to provide comments on this important guidance. Hello,Please find our uploaded comments from the American Neurogastroenterology and Motility Society (non-profit) medical society.  I could not find under the list of categories one for Medical Societies, so chose Health Care Association if the definition of category is for our society the submitter.Thank you, Comment from Vanda Pharmaceuticals, Inc. 